Sumitomo Chemical India (SUMICHEM) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
27 Jul, 2026Executive summary
Revenue grew 1% year-over-year to Rs. 1,063 crore (₹10,633.46 million) in Q1FY27, despite adverse agro-climatic conditions and subdued domestic demand.
Gross profit increased 4% YoY, with margin expansion to 39.2% due to pricing actions and favorable product mix.
EBITDA rose 6% YoY to Rs. 233 crore, with margin up 120 bps to 21.9%.
Net profit surged 20% YoY to Rs. 215 crore (₹2,148.30 million), aided by a Rs. 27 crore (₹268.96 million) insurance claim from a prior plant fire.
Export revenues grew 26% YoY, now comprising 16% of total revenue, offsetting weak domestic sales.
Financial highlights
Q1FY27 revenue: Rs. 1,063.3 crore (₹10,633.46 million, +1% YoY); gross profit: Rs. 416.7 crore (+4% YoY); gross margin: 39.2% (+111 bps YoY).
EBITDA: Rs. 233.3 crore (+6% YoY); EBITDA margin: 21.9% (+120 bps YoY).
Net profit: Rs. 215 crore (₹2,148.30 million, +20% YoY); net margin: 20.2% (+332 bps YoY).
Cash & equivalents at June 2026: Rs. 2,549 crore; net working capital days increased to 56 (from 43 YoY) due to seasonal inventory build-up.
Basic and diluted EPS for Q1 FY27 stood at ₹4.30, compared to ₹3.57 in Q1 FY26.
Outlook and guidance
Focus remains on sustainable growth via differentiated products, disciplined execution, and enhanced channel engagement.
Launches of Topgrain and Helibax planned for Q2FY27 to support future growth.
Performance is seasonal and depends on monsoon and climatic conditions.
Regulatory uncertainty remains regarding glyphosate usage, pending court resolution.
Improved monsoon progress and sowing activity expected to aid recovery in domestic demand.
Latest events from Sumitomo Chemical India
- Record profit, margin expansion, and a ₹1.30 dividend in FY26 amid regulatory risks.SUMICHEM
Q4 25/26 - 9MFY26 revenue rose 5% with margin gains, but Q3 saw profit drop from one-time Labour Code charge.SUMICHEM
Q3 25/26 - H1 FY26 delivered 9% revenue growth, robust cash flow, and new launches despite Q2 headwinds.SUMICHEM
Q2 25/26 - Q1FY25 saw strong revenue and profit growth, improved margins, and ongoing legal and seasonal risks.SUMICHEM
Q1 24/25 - Record H1 FY25 profit and margin growth driven by new products, exports, and strong demand outlook.SUMICHEM
Q2 24/25 - Q3FY25 saw robust revenue and profit growth, led by exports, with ongoing seasonal and regulatory risks.SUMICHEM
Q3 24/25 - Double-digit growth, record margins, and strong outlook, amid regulatory and climate risks.SUMICHEM
Q4 24/25 - Record Q1FY26 revenue and profit growth, with strong margins and ongoing regulatory risks.SUMICHEM
Q1 25/26